Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
05/14/2013 | US8440652 MST1 kinase inhibitors and methods of their use |
05/14/2013 | CA2731368C 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
05/14/2013 | CA2716369C Phenoxypropylamine compounds |
05/14/2013 | CA2611889C Substituted tetrahydroquinolines |
05/14/2013 | CA2589237C (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4homopiperazine hydrochloride dihydrate |
05/14/2013 | CA2557433C Quinazoline derivatives and therapeutic use thereof |
05/14/2013 | CA2546657C 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
05/14/2013 | CA2544814C Non-symmetrical gelling agent |
05/14/2013 | CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
05/14/2013 | CA2516624C 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
05/14/2013 | CA2393084C Immunoassay for neonicotinyl insecticides |
05/10/2013 | WO2013067434A1 Pak inhibitors for the treatment of fragile x syndrome |
05/10/2013 | WO2013067267A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine |
05/10/2013 | WO2013067264A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity |
05/10/2013 | WO2013066640A1 Substituted pyrazole analogues as rar antagonists |
05/10/2013 | WO2013064983A1 Benzenesulfonamide compounds and their use as therapeutic agents |
05/10/2013 | WO2013064919A1 Quinazoline derivatives with hsp90 inhibitory activity |
05/10/2013 | WO2013064883A1 Heteroaryl compounds as sodium channel blockers |
05/10/2013 | WO2013064521A1 Pesticidal compounds |
05/10/2013 | WO2013064519A1 Pesticidal compounds |
05/10/2013 | WO2013064468A1 Indole inhibitors of crac |
05/10/2013 | WO2013064465A1 New aryl-quinoline derivatives |
05/10/2013 | WO2013064461A2 Compounds with nematicidal activity |
05/10/2013 | WO2013064458A1 Herbicide/safener compositions containing n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides |
05/10/2013 | WO2013064450A1 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
05/10/2013 | WO2013064231A1 SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3) |
05/10/2013 | WO2013032668A3 Anatabine-enriched tobacco products |
05/10/2013 | WO2013006308A3 Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders |
05/10/2013 | WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors |
05/10/2013 | WO2012124311A8 Novel phenylpyridine derivative and drug containing same |
05/10/2013 | CA2854462A1 Pak inhibitors for the treatment of fragile x syndrome |
05/10/2013 | CA2854217A1 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
05/10/2013 | CA2854107A1 Herbicide/safener compositions containing n-(tetrazol-5-yl) aryl carboxylic acid amides and n-(triazol-5-yl) aryl carboxylic acid amides |
05/10/2013 | CA2853967A1 8-fluorophthalazin-1 (2h) -one compounds as inhibitors of btk activity |
05/10/2013 | CA2853439A1 Benzenesulfonamide compounds and their use as therapeutic agents |
05/10/2013 | CA2852700A1 Rod-like hepatitis c virus inhibitors containing the fragment {2-[4-(biphenyl-4-yl)-1h-imidazo-2-yl]pyrrolidine-1-carbonlymethyl}amine |
05/10/2013 | CA2850516A1 Substituted pyrazole analogues as rar antagonists |
05/10/2013 | CA2849945A1 New aryl-quinoline derivatives |
05/09/2013 | US20130116441 Intermediates and process for preparing a thrombin specific inhibitor |
05/09/2013 | US20130116440 Process of preparing a thrombin specific inhibitor |
05/09/2013 | US20130116439 Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds |
05/09/2013 | US20130116431 Novel HSP90 Inhibitor |
05/09/2013 | US20130116430 Novel nicotinamide derivative or salt thereof |
05/09/2013 | US20130116285 Chemical Compounds |
05/09/2013 | US20130116284 Lipoic acid and nitroxide derivatives and uses thereof |
05/09/2013 | US20130116283 Substituted indole derivatives |
05/09/2013 | US20130116281 Multiphoton Activable Quinoline Derivatives, Their Preparation and Their Uses |
05/09/2013 | US20130116279 Bicyclic heteroaryl inhibitors of pde4 |
05/09/2013 | US20130116278 Antimicrobial agents |
05/09/2013 | US20130116264 Novel Hetaryl (thio)carboxamide Compounds for Controlling Invertebrate Pests |
05/09/2013 | US20130116258 Androgen receptor modulators and uses thereof |
05/09/2013 | US20130116253 Novel HSP90 Inhibitor |
05/09/2013 | US20130116252 Novel HSP90 Inhibitor |
05/09/2013 | US20130116251 Novel HSP90 Inhibitor |
05/09/2013 | US20130116247 IRE-1alpha INHIBITORS |
05/09/2013 | US20130116246 8-fluorophthalazin-1(2h)-one compounds |
05/09/2013 | US20130116240 Indole compounds and pharmaceutical use thereof |
05/09/2013 | US20130116234 Aryl-quinoline derivatives |
05/09/2013 | US20130116233 Novel inhibitor compounds of phosphodiesterase type 10a |
05/09/2013 | US20130116231 Tyrosine kinase inhibitors |
05/09/2013 | US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
05/09/2013 | US20130116229 Novel inhibitor compounds of phosphodiesterase type 10a |
05/09/2013 | US20130116228 Thiazoles and pyrazoles useful as kinase inhibitors |
05/09/2013 | US20130116216 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof |
05/09/2013 | US20130116214 Heterocyclic ring compound |
05/09/2013 | US20130116206 Quinoline derivatives used as pet imaging agents |
05/09/2013 | US20130116169 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
05/09/2013 | US20130115194 Hepatitis c virus inhibitors |
05/09/2013 | US20130115193 Hepatitis C Virus Inhibitors |
05/09/2013 | US20130113367 Heterocyclic compound and organic light-emitting device including the same |
05/09/2013 | US20130112948 Heterocyclic compound and organic light-emitting diode including the same |
05/08/2013 | EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
05/08/2013 | EP2589599A1 Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors |
05/08/2013 | EP2589595A1 Agent for treating hcv infection |
05/08/2013 | EP2589592A1 Novel nicotinamide derivatives or salts thereof |
05/08/2013 | EP2589591A1 Compound with carbazole ring structure and organic electroluminescent element |
05/08/2013 | EP2589293A1 Herbicide safener compounds containing N-(Tetrazol-5-yl)- and N-(Triazol-5-yl)aryl carboxylic acid amides |
05/08/2013 | EP2588473A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
05/08/2013 | EP2588472A1 Rupatadine salt as an antihistaminic agent |
05/08/2013 | EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
05/08/2013 | EP2588470A1 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity |
05/08/2013 | EP2588469A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
05/08/2013 | EP2588468A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
05/08/2013 | EP2588467A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
05/08/2013 | EP2588466A1 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) |
05/08/2013 | EP2588465A1 Sgc stimulators |
05/08/2013 | EP2588458A1 Novel tetrahydroquinoline derivatives |
05/08/2013 | EP2588456A1 Novel microbiocidal dioxime ether derivatives |
05/08/2013 | EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
05/08/2013 | EP2588453A1 Compositions and methods for modulating the wnt signaling pathway |
05/08/2013 | EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
05/08/2013 | EP2588104A1 Isoindolone m1 receptor positive allosteric modulators |
05/08/2013 | CN103097376A Pyridine compounds for controlling invertebrate pests ii |
05/08/2013 | CN103097375A Cyclohexyl-azetidinyl antagonists of CCR2 |
05/08/2013 | CN103097374A Metalloenzyme inhibitor compounds |
05/08/2013 | CN103097373A Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
05/08/2013 | CN103097361A 1-(aryl methyl)-quinazoline-2,4-dione as parp inhibitor and its application |
05/08/2013 | CN103097354A Substituted benzamide compounds |
05/08/2013 | CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
05/08/2013 | CN103088007A Crystal structure of enterovirus 71 type 2A protease and application of crystal structure in drug design |